Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Halloran

Sports Medicine Leawood, KS Medical Doctor

NPI 1841561750 CMS profile 128776

3651 College Blvd, Leawood, KS 66211

Open in the dashboard

General payments

$169,936

244 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Halloran of Leawood, KS is reported in the CMS Open Payments database as having received $169,936 across 244 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,156 62
2024 General $21,470 51
2023 General $23,155 23
2022 General $44,211 23
2021 General $17,400 26
2020 General $6,160 14
2019 General $23,385 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Halloran
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to James Halloran were reported at $34,156. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year James Halloran Sports Medicine median Middle half National median
2019 $23,385 $1,176 $199–$4,249 $163
2020 $6,160 $708 $96–$2,890 $114
2021 $17,400 $1,213 $152–$3,994 $132
2022 $44,211 $1,230 $159–$3,998 $149
2023 $23,155 $584 $146–$2,836 $160
2024 $21,470 $628 $163–$3,168 $164
2025 $34,156 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Linvatec Corporation $62,492 26 payments
  2. TriMed, Inc. $41,466 69 payments
  3. Treace Medical Concepts, Inc. $27,018 36 payments
  4. In2Bones USA, LLC $22,343 16 payments
  5. Titan Surgical Group, LLC $7,278 29 payments
  6. Arthrex, Inc. $2,613 12 payments
  7. Exactech, Inc. $2,195 7 payments
  8. Stryker Corporation $1,838 21 payments
  9. Osteomed LLC $750 1 payment
  10. Paragon 28, Inc. $567 7 payments
  11. Other $1,376 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $44,663 19 payments
  2. Royalty or License $41,445 18 payments
  3. Acquisitions $26,082 5 payments
  4. Travel and Lodging $24,330 44 payments
  5. Food and Beverage $12,417 142 payments
  6. Honoraria $12,250 6 payments
  7. Education $5,153 5 payments
  8. Compensation for serving as faculty or as a speaker for a medical education program $3,500 1 payment
  9. Entertainment $96 4 payments
Products named General payments · program years 2019–2025
  1. Lapiplasty System $26,903 33 payments
  2. AVENGER RADIAL HEAD, +4 STEMS $26,082 5 payments
  3. COLINK NEOFUSE $20,328 7 payments
  4. HERCULES SUTURE ANCHOR SYSTEM In2bones $19,465 6 payments
  5. Tools - AFS $13,441 20 payments
  6. CoLink $12,720 10 payments
  7. Hercules Orthopedics $11,622 7 payments
  8. HERCULES SUTURE ANCHOR SYSTEM In2bones $9,495 4 payments
  9. HERCULES In2bones $6,114 3 payments
  10. Tools - FPS $3,500 1 payment
  11. Other $10,996 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

183

Median for Orthopedic Surgery: 203

Drug cost

$1,102

Median for Orthopedic Surgery: $1,433

Branded share of claims

22.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 46 $283
Ondansetron Odt Ondansetron Brand 41 $273
Oxycodone Hcl Generic 42 $272
Gabapentin Generic 41 $163
Meloxicam Generic 13 $112

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$72,301

Of which drugs: $1,334

Medicare patients

267

Average age 73

Services billed

3,210

178 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 67%
Ischemic heart disease 20%
Depression 19%
Osteoporosis 19%
Diabetes 16%
Atrial fibrillation 15%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 57 382 $285

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

244 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record